Organigram Holdings Inc. Selling, General and Administrative Expense of Revenue

Selling, General and Administrative Expense of Revenue of OGI for past 10 years: annual, quarterly and twelve month trailing (TTM) including Selling, General and Administrative Expense of Revenue growth rates and interactive chart.


Highlights and Quick Summary

  • Selling, General and Administrative Expense of Revenue for the quarter ending February 28, 2022 was 46.54% (a 4.19% increase compared to previous quarter)
  • Year-over-year quarterly Selling, General and Administrative Expense of Revenue decreased by -30.64%
  • Annual Selling, General and Administrative Expense of Revenue for 2021 was 66.01% (a 23.29% increase from previous year)
  • Annual Selling, General and Administrative Expense of Revenue for 2020 was 53.54% (a 4.26% increase from previous year)
  • Annual Selling, General and Administrative Expense of Revenue for 2019 was 51.35% (a -59.02% decrease from previous year)
  • Twelve month Selling, General and Administrative Expense of Revenue ending February 28, 2022 was 53.14% (a -10.36% decrease compared to previous quarter)
  • Twelve month trailing Selling, General and Administrative Expense of Revenue decreased by -17.68% year-over-year
Trailing Selling, General and Administrative Expense of Revenue for the last four month:
28 Feb '22 30 Nov '21 31 Aug '21 31 May '21
53.14% 59.28% 64.9% 64.55%
Visit stockrow.com/OGI for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Selling, General and Administrative Expense of Revenue of Organigram Holdings Inc.

Most recent Selling, General and Administrative Expense of Revenueof OGI including historical data for past 10 years.

Interactive Chart of Selling, General and Administrative Expense of Revenue of Organigram Holdings Inc.

Organigram Holdings Inc. Selling, General and Administrative Expense of Revenue for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 46.54%
2021 44.67% 59.8% 67.1% 76.95% 66.01%
2020 59.69% 56.84% 63.0% 65.95% 53.54%
2019 43.89% 97.58% 44.88% 36.11% 51.35%
2018 44.22% 0.0% 125.3%
2017 137.21%
2016 66.4%

Business Profile of Organigram Holdings Inc.

Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic